Novartis investigators find genetic explanations for why some young patients relapse.

Zebrafish imaging sheds light on human neurological conditions.

Researchers improve our understanding about how compounds bind to proteins in the cell membrane—and the membrane itself.

Compounds that block the production of damaging molecules might shed light on their role in disease—and lead to new therapies.

Genome editing advances drug discovery in biomedical research.

Blocking an inflammatory pathway may offer a new way to treat autoimmune disease.

Novartis opens up a path of research to protect proteins that guard against cancer.

A Novartis team blazes new trails with an experimental treatment for spinal muscular atrophy.

An investigational treatment for an uncommon immunodeficiency disease races into clinical studies.

Functional genomics study reveals a potential approach for tackling glioblastoma, pancreatic cancer and other tumors.